Abstract
e15599Background: Circulating tumor DNA (ctDNA) is a promising marker for monitoring tumor burden and therapy response in metastatic colorectal cancer (mCRC). The AIO KRK 0207 trial investigated di...
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have